ABSTRACT
Abstract Introduction The aim of this study was to examine the effect of group cognitive-behavioral therapy (GCBT) on pathological internet use (PIU). Method The study applied a group randomized controlled trial design to assign participants to intervention and control groups. A total of 40 college students aged 18 to 30 who were pathological internet users (PIUs) participated in this study and were randomly assigned to treatment and control groups. Participants completed a self-report scale entitled the Problematic Internet Use Scale (PIUS) at three time points. The intervention lasted 8 weeks. The data collected were statistically analyzed using repeated-measures analysis of variance (ANOVA). Results The results showed that GCBT has significant efficacy, decreasing the symptoms of PIU among the GCBT participants compared to those in the control group and that the improvements were maintained at follow-up. We also found a significant interaction effect by time for PIU. Conclusion From the study findings, we can conclude that GCBT has significant benefit for mitigating the severity of PIU in college students. Therefore, mental health professionals are encouraged to explore the benefits of GCBT in treating symptoms associated with PIU in school settings and beyond.
ABSTRACT
This paper presents a systematic review of extant research investigating the effectiveness of Internet-based group cognitive behavioral therapy （IGCBT） for depression and anxiety symptoms with an emphasis on the treatment modalities， treatment protocols， efficacy and mechanism， together with a summary of research limitations and suggestions for future research. Cognitive behavioral therapy （CBT） is a structured， short-term and present-oriented psychotherapeutic treatment， its Internet- and group-delivered modalities have led to its wider application， and has proven to be clinically effective in alleviating depression and anxiety symptoms caused by different diseases， whereas some drawbacks have been reported. Thus this paper elaborates the clinical application， therapeutic effect and underlying mechanisms of IGCBT intervention for depression and anxiety symptoms， so as to provide references for its future application. ［Funded by the Natural Science Foundation of the Inner Mongolia Autonomous Region （number， 2019MS03038）
ABSTRACT
Objective: To evaluate the effectiveness of group cognitive-behavioral therapy (GCBT) for the treatment of adolescents with obsessive compulsive disorder (OCD). Methods: This review was registered in PROSPERO under number CRD42020158475. Five databases (PubMed, Virtual Health Library, Web of Science, Scopus, and PsycINFO) were searched. After applying the inclusion and exclusion criteria, 13 studies were analyzed in the qualitative synthesis (i.e., systematic review) and eight in the quantitative synthesis (i.e., meta-analysis). For the latter, fixed-effect modeling was used to assess the primary outcome (i.e., OCD symptoms). Results: The main findings suggest that GCBT is effective in reducing the symptoms of OCD in adolescents (d = -1.32). However, these results must be interpreted with caution, since all of the included studies showed some bias in their design. Conclusions: GCBT is effective in reducing OCD symptoms in adolescents.
ABSTRACT
Objective To explore the efficacy of group cognitive-behavioral therapy(GCBT) for diabetic patients with anxiety and depression. Methods In this randomized control study, 42 patients was recruited for treatment of diabetes and allocated them in a randomized manner (1:1) into two groups to receive either 10-weeks GCBT plus regular education or regular education alone.Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Self-rating Depression Scale(SDS), and fasting blood glucose were measured and evaluated before and after treatment. Results After 10 weeks of intervention, the total scores of HAMD, HAMA, and SDS were significantly decreased.Compared with the control group, repeated measures of ANOVA revealed a significant group-by-time interaction(F=6.801, 10.30, 5.02, P=0.013, 0.003, 0.031).The difference of HAMD was negatively correlated with disease duration and education (r=-0.486, -0.541, P=0.030, 0.014), and the difference of SDS was obviously correlated with gender, as the SDS score of women decreased more significantly (r=0.582, P=0.007). Conclusion Group cognitive-behavioral therapy can help to improve the mood of diabetic patients with anxiety and depression, rehabilitating their social function and life quality.
ABSTRACT
Objective To explore the treatment effect of group cognitive behavioral therapy (GCBT) for patients with insomnia.Methods Two hundred and forty-one cases of insomnia were collected in the department of Sleep and Neurology Psychological in D aping Hospital and Field Surgery Research Institute of Army Medical University from March 2016 to June 2017.They were randomly divided into GCBT group (n=128) and pharmacotherapy group (n=113),and the treatment last for 8 weeks for each group.Then the differences of the sleep parameters,Insomnia Severity Index (ISI) scores,Hamilton Depression Scale (HAMD)scores and Hamilton Anxiety Scale (HAMA) scores were compared in two groups at per-treatment,four-week treatment time point and eight-week treatment time point.Results At the four week treatment time point,the differences of sleep onset latency (SOL),total sleep time (TST),time in bed (TIB),number of awakenings (NOA) and insomnia severity index (ISI) in GCBT group compared to pharmacotherapy group were statistically significant (P＜0.05).While the differences of sleep efficiency (SE),HAMA and HAMD were of no statistically significant difference (P＞0.05).At the eight week treatment time point,the differences of SOL,SE,NOA,HAMA,HAMD and ISI in GCBT group compared to pharmacotherapy group were statistically significant (P＜0.05),and there is no significant difference in TST and TIB (P＞0.05).Conclusion GCBT and pharmacotherapy can improve insomnia symptoms,reduce the level of anxiety and insomnia severity.GCBT can also reduce the level of depression,although GCBT improve insomnia symptoms were slower than pharmacotherapy,but curative cffect is superior to pharmacotherapy,and it should be popularized in clinic.
ABSTRACT
OBJECTIVES: The overuse of the Internet among adolescents has increased dramatically in recent years, leading to pathological or problematic Internet use. Cognitive behavioral therapy (CBT) is known to be effective for the treatment of problematic Internet use, particularly for adolescents. The aim of the present study was to evaluate the therapeutic efficacy of group CBT for problematic Internet use in adolescents. METHODS: A total of 17 patients aged 12–17 years who met Young's diagnostic questionnaire criteria of problematic Internet use participated in a school-based eight-session group CBT program. The level of problematic Internet use among participating students was measured using Young's Internet Addiction Scale (IAS). Depression and anxiety levels were evaluated using the Children's Depression Inventory (CDI) and the State-Trait Anxiety Inventory (STAI), respectively. Each construct was assessed at baseline, immediately after the intervention, and at a one-month follow-up visit. Statistical significance was based on a p-value of < 0.05. RESULTS: Immediately after the program, the IAS, CDI, and State Anxiety Inventory (SAI) scores were significantly lower than before the program. At the one-month follow-up assessment, the IAS scores remained low, and the CDI and SAI scores were even lower than immediately after the program. CONCLUSION: Group CBT was effective for adolescents with problematic Internet use, and was also demonstrated to improve depression and anxiety.
Subject(s)
Adolescent , Humans , Anxiety , Cognitive Behavioral Therapy , Depression , Follow-Up Studies , InternetABSTRACT
Objective To explore the efficacy of group cognitive behavioral therapy for improving depressive symptoms and social functional in patients with major depressive disorder.Methods A total of 160 patients with major depressive disorder were randomly divided into intervention group (n=80) and control group (n=80).Intervention group was treated with conventional antidepressants combined with group cognitive behavioral therapy.Control group was treated with one conventional antidepressants.All participants were assessed with Hamilton Depression Scale (HAMD)and Scale of Social function of Psychosis Inpatients (SSFPI) before and 8 weeks after the treatment.Results After 8 weeks treatment,the scores of HAMD (14.76±9.48) was significantly reduced and the scores of SSFPI(30.09±4.34) were significantly increased in intervention group compared with the baseline ((37.91± 10.58),(12.40±2.56),all P＜0.01).The scores of HAMD were significantly lower and the scores of SSFPI were significantly higher in intervention group than that in control group((20.71±7.85),(22.63±3.63),all P＜0.01).Conclusion Group cognitive behavioral therapy is effective for major depressive disorder patients by reducing depressive symptom and improving social function.
ABSTRACT
Objective:To explore the efficacy of group cognitive-behavioral therapy (GCBT) to generalized anxiety disorder (GAD).Methods:In this randomized controlled trial,the control group (n =23) and the intervention group (n =33) were included,all of the participants received duloxetine (30-120 mg/d) as pharmacotherapy.The intervention group received 8 group cognitive-behavioral therapy sessions weekly,90 minutes for each time.Assessments were conducted with the Hamilton Anxiety Scale (HAMA),Hamilton Depression Scale (HMAD) and Clinical Global Impression (CGI) at baseline,mid-treatmentand post-treatment.CGI included three factors,the severity of illness (SI),the globalimprovement (GI) and the efficacy index (EI).Results:The repeated measures analysis of variance of HAMA showed that,there were statistical significance on the HAMA for interaction between measure time and group processing (F =4.35,P ＜ 0.05).Compared with the control group,the intervention group got higher decreased scores of HAMA at the 4th week and 8th week,and higher prevalence of being cured and efficient at the 4th week.At the 8th week,the decreased scores of HMAD were higher in the intervention group than in the control group,and the scores of CGI-SI and the CGI-IE were lower in the intervention group.Conclusion:It suggests that group cognitive-behavioral therapy combined with pharmacotherapy could be earlier to be effective,and the symptoms of anxiety,depression and the state of illness could be improved more significantly compared with pharmacotherapy alone.
ABSTRACT
Objective To investigate the Chaihu Shugan decoction combined with Group cognitive behavioral therapy on curative effect and neurologic impairment in patients with depression after stroke. Methods 80 PSD patients were randomly divided into our hospital encephalopathy rehabilitation were selected as control group and observation group, 40 cases in each group. The routine drug treatment and rehabilitation training for all patients with Deanxit tablet. The observation group added ChaiHuShuGan Decoction and group cognitive behavioral therapy in the control group based on the treatment. Two groups of patients with 24h before treatment and after 8 weeks of treatment, the Hamilton Depression Scale, the degree of neural function defect scale and evaluation index of Basel. Results After 8 weeks treatment, the total effective rate of the observation group was 95% (38 / 40), and the control group was 75% (40/30), the difference was statistically significant (P<0.05). The improvement of HAMD, NIHSS and BI scores in the observation group were significantly better than those in the control group, the difference was statistically significant (P<0.05). Conclusion ChaiHuShuGan Decoction has synergistic effect with Group cognitive behavioral therapy in the treatment of PSD can significantly improve the symptoms of depression and neurologic impairment, and can improve the quality of life of patients.
ABSTRACT
ABSTRACTBACKGROUND AND OBJECTIVES:Group cognitive-behavioral therapy has shown to be effective for chronic pain management in the international literature. However, the need to bring evidence-based practices to health services requires that therapies like this are implemented and evaluated in Brazil. This study has not intended to evaluate the efficacy of group cognitive-behavioral therapy for chronic pain adult patients, but rather to identify how studies in this area are being performed by Brazilian investigators.CONTENTS:A search was carried out about Brazilian studies published in the last two decades (1994-2014), evaluating the efficacy of group cognitive-behavioral therapy for adults with non-malignant chronic pain. Health Virtual Library databases were used and search terms were: Chronic pain “and” Psychology “or” Cognitive-Behavioral Therapy. Evaluated variables were clinical and socio-demographic characteristics, pre and post-intervention evaluation tools, sessions' structure (sessions number and duration), primary results, and evaluation of the quality of studies by means of the PEDro scale.CONCLUSION:Six out of 816 articles available were selected for analysis, because they were the only ones to meet chosen search criteria. One should stress the scarcity of Brazilian studies in the area, the use of exclusively subjective evaluations aimed at unidimensional pain aspects, and the concern with the methodological quality of studies, especially with regard to internal validity.
RESUMOJUSTIFICATIVA E OBJETIVOS:A terapia cognitivo-comportamental em grupo tem se mostrado eficiente no tratamento para dor crônica, na literatura internacional. Entretanto, a necessidade de trazer práticas baseadas em evidências para os serviços de saúde exige que tratamentos como este sejam implantados e avaliados no Brasil. O presente estudo não pretendeu analisar a eficácia da terapia cognitivo-comportamental em grupo para adultos com dor crônica, mas identificar como os estudos nessa área têm sido conduzidos por pesquisadores brasileiros.CONTEÚDO:Realizou-se uma busca de estudos brasileiros publicados nos últimos 20 anos (1994-2014), que avaliaram a eficácia da terapia cognitivo-comportamental em grupo para adultos com dor crônica não maligna. Utilizaram-se as bases de dados da Biblioteca Virtual em Saúde, e os termos de busca foram: Dor Crônica “and” Psicologia “or” Terapia Cognitivo-Comportamental. As variáveis avaliadas foram características clinicas e sócio-demográficas dos participantes, instrumentos de avaliação pré e pós-intervenção, estrutura das sessões (quantidade e duração das sessões), principais resultados, e análise da qualidade dos estudos realizada por meio da escala PEDro.CONCLUSÃO:Seis dos 816 artigos disponibilizados foram selecionados para análise, pois foram os únicos a atingir os critérios de busca escolhidos. Destaca-se a escassez de estudos brasileiros na área, o uso de avaliações exclusivamente subjetivas e voltadas a aspectos unidimensionais da dor, e a preocupação com a qualidade metodológica dos estudos, sobretudo no que se refere à validade interna.
ABSTRACT
OBJECTIVES: Cognitive behavioral therapy for treatment of schizophrenia was designed as a psychological therapy for treatment of drug resistant patients with schizophrenia. This therapy is currently being widely applied from early psychosis to chronic condition. The aim of this article is to review the main results of research articles on cognitive behavioral therapy of schizophrenia and prompt practicing the therapy in Korean mental health services. METHODS: The important original and review articles were referred in order to understand the main results of research from published international books, and the English website Pubmed was searched in order to update recent findings. This article reviewed the results of four areas of different phases and types of cognitive behavioral therapy for treatment of schizophrenia: drug resistant chronic patients, acute psychotic state, prodromal phase, and group cognitive behavioral therapy. RESULTS: Cognitive behavioral therapy for treatment of drug resistant patients with schizophrenia can attenuate the positive and general symptoms more than that for patients who receive supportive psychotherapy or treatment as usual. However, the effect appears to be less than previously expected, small to moderate. Cognitive behavioral therapy for patients of acute psychotic state can reduce the time of recovery from acute psychotic symptoms by approximately 25%. The result of cognitive behavioral therapy for patients of prodromal phase shows that the therapy can reduce the rate of transition to schizophrenia by up to one third. Group behavioral therapy has recently been tested. Group therapists have suggested that the therapy should be applied through the way of groups with relatively homogenous symptoms. However, whether the therapy can reduce the severity of hallucination in the voice hearer group is inconclusive. CONCLUSION: Alongside pharmacotherapy for treatment of schizophrenia, cognitive behavioral therapy is a distinct psychological therapy for attenuation of psychotic symptoms. The effect of cognitive behavioral therapy appears to last for one year and requires additional therapeutic sessions after one year. The effect is not still clear in group cognitive behavioral therapy for treatment of schizophrenia. Cognitive behavioral therapy for treatment of schizophrenia should be practiced widely in the Korean mental health system.